2 finançaments - 6.304€

dades disponibles des de l'any 2019

2020

  1. Evaluation of the anti-CD160 antibodies in in vivo models.

    euro 5.000,00

2019

  1. Evaluation of anti-CD160 antibodies in "in vivo" models.

    euro 1.304,35